91 related articles for article (PubMed ID: 17299394)
21. Successful treatment of metastatic refractory gestational choriocarcinoma with pembrolizumab: A case for immune checkpoint salvage therapy in trophoblastic tumors.
Clair KH; Gallegos N; Bristow RE
Gynecol Oncol Rep; 2020 Nov; 34():100625. PubMed ID: 32964090
[TBL] [Abstract][Full Text] [Related]
22. Avelumab in Patients With Gestational Trophoblastic Tumors With Resistance to Single-Agent Chemotherapy: Cohort A of the TROPHIMMUN Phase II Trial.
You B; Bolze PA; Lotz JP; Massardier J; Gladieff L; Joly F; Hajri T; Maucort-Boulch D; Bin S; Rousset P; Devouassoux-Shisheboran M; Roux A; Alves-Ferreira M; Grazziotin-Soares D; Langlois-Jacques C; Mercier C; Villeneuve L; Freyer G; Golfier F
J Clin Oncol; 2020 Sep; 38(27):3129-3137. PubMed ID: 32716740
[TBL] [Abstract][Full Text] [Related]
23. Thoracoscopic Surgery to Treat Lung Metastases from Refractory Choriocarcinoma.
Zhao L; Qin Y; Ma D; Li L; Han Z; Li S; Liu H
Cancer Manag Res; 2020; 12():3851-3858. PubMed ID: 32547221
[TBL] [Abstract][Full Text] [Related]
24. A review on management of gestational trophoblastic neoplasia.
Sharami SRY; Saffarieh E
J Family Med Prim Care; 2020 Mar; 9(3):1287-1295. PubMed ID: 32509606
[TBL] [Abstract][Full Text] [Related]
25. Management and risk factors of recurrent gestational trophoblastic neoplasia: An update from 2004 to 2017.
Kong Y; Zong L; Cheng H; Jiang F; Wan X; Feng F; Ren T; Zhao J; Yang J; Xiang Y
Cancer Med; 2020 Apr; 9(7):2590-2599. PubMed ID: 32022487
[TBL] [Abstract][Full Text] [Related]
26. Role of AhR in regulating cancer stem cell-like characteristics in choriocarcinoma.
Wu C; Yu S; Tan Q; Guo P; Liu H
Cell Cycle; 2018; 17(18):2309-2320. PubMed ID: 30311543
[TBL] [Abstract][Full Text] [Related]
27. High-risk gestational choriocarcinoma with an unusual presentation and the treatment course of refractory or quiescent/minimally invasive disease.
Nagai Y; Nakamoto T; Nakasone T; Taira Y; Aoki Y
Gynecol Oncol Rep; 2018 Nov; 26():56-59. PubMed ID: 30302364
[TBL] [Abstract][Full Text] [Related]
28. Identification and characterisation of NANOG+/ OCT-4
Balahmar RM; Boocock DJ; Coveney C; Ray S; Vadakekolathu J; Regad T; Ali S; Sivasubramaniam S
Oncotarget; 2018 Jan; 9(6):7054-7065. PubMed ID: 29467949
[TBL] [Abstract][Full Text] [Related]
29. Expression patterns of maspin and mutant p53 are associated with the development of gestational trophoblastic neoplasia.
Sun P; Wu Q; Ruan G; Zheng X; Song Y; Zhun J; Wu L; Gotlieb WH
Oncol Lett; 2016 Nov; 12(5):3135-3142. PubMed ID: 27899973
[TBL] [Abstract][Full Text] [Related]
30. Gestational trophoblastic tumours: an update for 2014.
Froeling FE; Seckl MJ
Curr Oncol Rep; 2014 Nov; 16(11):408. PubMed ID: 25318458
[TBL] [Abstract][Full Text] [Related]
31. AKR1C3 overexpression mediates methotrexate resistance in choriocarcinoma cells.
Zhao J; Xiang Y; Xiao C; Guo P; Wang D; Liu Y; Shen Y
Int J Med Sci; 2014; 11(11):1089-97. PubMed ID: 25170291
[TBL] [Abstract][Full Text] [Related]
32. Management of Chemoresistant and Quiescent Gestational Trophoblastic Disease.
Ngu SF; Chan KK
Curr Obstet Gynecol Rep; 2014; 3(1):84-90. PubMed ID: 24533232
[TBL] [Abstract][Full Text] [Related]
33. Thoracotomy in refractory gestational trophoblastic neoplasia with lung metastasis after normalization of serum beta human chorionic gonadotropin (β-hCG) with salvage chemotherapy.
Feng F; Hu H; Wu L; Ren T; Wan X; Xiang Y
Onco Targets Ther; 2014; 7():171-6. PubMed ID: 24511240
[TBL] [Abstract][Full Text] [Related]
34. Early prediction of treatment resistance in low-risk gestational trophoblastic neoplasia using population kinetic modelling of hCG measurements.
You B; Harvey R; Henin E; Mitchell H; Golfier F; Savage PM; Tod M; Wilbaux M; Freyer G; Seckl MJ
Br J Cancer; 2013 May; 108(9):1810-6. PubMed ID: 23591194
[TBL] [Abstract][Full Text] [Related]
35. Puerperal choriocarcinoma.
Beavington L; Mossa M
BMJ Case Rep; 2011 Feb; 2011():. PubMed ID: 22714612
[TBL] [Abstract][Full Text] [Related]
36. Trophoblastic neoplasms express fatty acid synthase, which may be a therapeutic target via its inhibitor C93.
Ueda SM; Mao TL; Kuhajda FP; Vasoontara C; Giuntoli RL; Bristow RE; Kurman RJ; Shih IeM
Am J Pathol; 2009 Dec; 175(6):2618-24. PubMed ID: 19893031
[TBL] [Abstract][Full Text] [Related]
37. Gestational trophoblastic neoplasia: an update.
Morgan JM; Lurain JR
Curr Oncol Rep; 2008 Nov; 10(6):497-504. PubMed ID: 18928664
[TBL] [Abstract][Full Text] [Related]
38. A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia.
Powles T; Savage PM; Stebbing J; Short D; Young A; Bower M; Pappin C; Schmid P; Seckl MJ
Br J Cancer; 2007 Mar; 96(5):732-7. PubMed ID: 17299394
[TBL] [Abstract][Full Text] [Related]
39. [Clinical analysis of patients with relapsed and chemo-resistant gestational trophoblastic neoplasia].
Zhou Y; Feng FZ; Xiang Y; Wan XR
Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):804-7. PubMed ID: 21211275
[TBL] [Abstract][Full Text] [Related]
40. Prognosis of patients with relapsed and chemoresistant gestational trophoblastic neoplasia transferred to the Peking Union Medical College Hospital.
Feng F; Xiang Y; Wan X; Zhou Y
BJOG; 2010 Jan; 117(1):47-52. PubMed ID: 19874291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
